4.4 Article

Pooled Safety Analysis of Baricitinib in Adult Participants with Atopic Dermatitis in the Japanese Subpopulation from Six Randomized Clinical Trials

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Dermatology

Pooled safety analysis of baricitinib in adult patients with atopic dermatitis from 8 randomized clinical trials

T. Bieber et al.

Summary: This study reports pooled safety data for baricitinib in patients with moderate-to-severe AD, confirming the established safety profile of baricitinib in this population.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2021)

Article Dermatology

Impact of baricitinib in combination with topical steroids on atopic dermatitis symptoms, quality of life and functioning in adult patients with moderate-to-severe atopic dermatitis from the BREEZE-AD7 Phase 3 randomized trial

A. Wollenberg et al.

Summary: Baricitinib plus TCS showed significant improvements in HRQoL, work productivity, and life functioning in patients with moderate-to-severe AD, indicating its potential as an effective treatment option.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2021)

Letter Dermatology

Increased Risk of Cutaneous and Systemic Infections in Atopic Dermatitis-A Cohort Study

Sinead M. Langan et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2017)

Review Allergy

Japanese Guideline for Atopic Dermatitis 2014

Ichiro Katayama et al.

ALLERGOLOGY INTERNATIONAL (2014)

Letter Dermatology

Japanese-Specific Filaggrin Gene Mutations in Japanese Patients Suffering from Atopic Eczema and Asthma

Rinko Osawa et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2010)

Article Dermatology

Prevalence of atopic dermatitis in Japanese adults

T Muto et al.

BRITISH JOURNAL OF DERMATOLOGY (2003)